Outlook Therapeutics Inc (OTLK)
6.04
-0.01
(-0.17%)
USD |
NASDAQ |
Nov 04, 16:00
6.055
+0.02
(+0.25%)
After-Hours: 20:00
Outlook Therapeutics Max Drawdown (5Y): 98.82% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.82% |
| September 30, 2024 | 98.82% |
| August 31, 2024 | 98.82% |
| July 31, 2024 | 98.82% |
| June 30, 2024 | 98.82% |
| May 31, 2024 | 98.82% |
| April 30, 2024 | 98.82% |
| March 31, 2024 | 98.82% |
| February 29, 2024 | 98.82% |
| January 31, 2024 | 98.82% |
| December 31, 2023 | 98.82% |
| November 30, 2023 | 98.82% |
| October 31, 2023 | 98.82% |
| September 30, 2023 | 98.82% |
| August 31, 2023 | 98.82% |
| July 31, 2023 | 98.82% |
| June 30, 2023 | 98.82% |
| May 31, 2023 | 98.82% |
| April 30, 2023 | 98.82% |
| March 31, 2023 | 98.82% |
| February 28, 2023 | 98.82% |
| January 31, 2023 | 98.82% |
| December 31, 2022 | 98.82% |
| November 30, 2022 | 98.82% |
| October 31, 2022 | 98.82% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.82% |
| August 31, 2022 | 98.82% |
| July 31, 2022 | 98.82% |
| June 30, 2022 | 98.82% |
| May 31, 2022 | 98.82% |
| April 30, 2022 | 98.82% |
| March 31, 2022 | 98.82% |
| February 28, 2022 | 98.82% |
| January 31, 2022 | 98.82% |
| December 31, 2021 | 98.82% |
| November 30, 2021 | 98.82% |
| October 31, 2021 | 98.82% |
| September 30, 2021 | 98.82% |
| August 31, 2021 | 98.82% |
| July 31, 2021 | 98.82% |
| June 30, 2021 | 98.82% |
| May 31, 2021 | 98.82% |
| April 30, 2021 | 98.82% |
| March 31, 2021 | 98.82% |
| February 28, 2021 | 98.82% |
| January 31, 2021 | 98.82% |
| December 31, 2020 | 98.82% |
| November 30, 2020 | 98.82% |
| October 31, 2020 | 98.82% |
| September 30, 2020 | 98.82% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.90%
Minimum
Nov 2019
98.82%
Maximum
Mar 2020
98.81%
Average
98.82%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Imunon Inc | 99.38% |
| Cormedix Inc | 93.38% |
| Brainstorm Cell Therapeutics Inc | 99.30% |
| Predictive Oncology Inc | 99.94% |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -36.56 |
| Beta (5Y) | 0.6243 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 109.4% |
| Historical Sharpe Ratio (5Y) | -0.2605 |
| Historical Sortino (5Y) | -0.4616 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.92% |